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p97/VCP/Cdc48psses two p97/VCP/Cdc48p homologues, named CDC-48.1 (C06A1.1) and CDC-48.2
(C41C4.8), and their expression patterns and levels are differently regulated. To clarify the regulatory
mechanisms of differential expression of two p97 proteins of C. elegans, we performed detailed deletion
analysis of their promoter regions. We found that the promoter of cdc-48.1 contains two regions necessary for
embryonic and for post-embryonic expression, while the promoter of cdc-48.2 contains the single region
necessary for embryonic expression. In particular, two elements (Element A and Element B) and three
conserved boxes (Box a, Box b and Box c) were essential for cdc-48.1 expression in embryos and at post-
embryonic stages, respectively. By using South-Western blotting and MALDI-TOF MS analysis, we identiﬁed
HMG-12 and CAR-1 as proteins that bind to Element A and Element B, respectively, from the embryonic nuclear
extract. Importantly, we found the decreased expression of p97 in embryos prepared from hmg-12(RNAi) or
car-1(RNAi) worms. These results indicate that both HMG-12 and CAR-1 play important roles in embryonic
expression of cdc-48.1.
© 2008 Elsevier Inc. All rights reserved.Introductionp97 (also called VCP in higher eukaryotes and Cdc48p in yeast) is a
member of the type II AAA (ATPases associated with diverse cellular
activities) proteins and is evolutionarily conserved from archaebac-
teria to human (Woodman, 2003; Wang et al., 2004). As is charac-
teristic of the AAAprotein, p97 forms a homo-hexamer that hydrolyzes
ATP to achieve its various cellular functions (Zhang et al., 2000). The
common function of p97 is believed to catalyze the ATP-dependent
protein conformational change; unfolding of proteins and disassembly
of protein complexes (Zhang et al., 2002).
p97 is involved in a variety of cellular processes, including ERAD
(endoplasmic reticulum-associated protein degradation) (Ye et al., 2001,
2003), homotypic membrane fusion (Kondo et al., 1997), transcriptional
regulation (Dai et al., 1998; Rape et al., 2001; Shcherbik et al., 2003),
cell-cycle regulation (Moir et al., 1982; Dai and Li, 2001), and other
protein quality control activities (Wang et al., 2004; Ye, 2006). These
speciﬁcities are mainly determined by differential binding of distinct
cofactors/adaptor proteins, such asUfd1/Npl4, Ubx2, p47, and p37 to thegura),
ogy Research Center, Ehime
l rights reserved.N-terminal domain of p97 (Kondo et al., 1997; Schuberth and
Buchberger, 2005; Uchiyama et al., 2006; Ye, 2006; Pye et al., 2007).
Recent studies of gene-disrupted mutants have revealed that p97 is
essential for Saccharomyces cerevisiae (Fröhlich et al., 1991), Drosophila
melanogaster (León andMcKearin, 1999), Caenorhabditis elegans (Yama-
naka et al., 2004), and mouse (Müller et al., 2007), suggesting that p97
plays a fundamental role within both unicellular and multicellular or-
ganisms. In addition to many essential cellular functions, p97 is in-
volved in the clearance of protein aggregates, such as polyglutamine-
induced protein aggregation (Yamanaka et al., 2004; Kobayashi et al.,
2007). It is interesting tomention that inclusion bodymyopathy associa-
ted with Paget disease of bone and frontotemporal dementia has been
demonstrated to be caused by mutations in p97 (Watts et al., 2004).
C. elegans uniquely possesses two p97 homologues, named CDC-
48.1 (C06A1.1) and CDC-48.2 (C41C4.8), although p97 is encoded by a
single gene in most of other organisms, such as human, mouse, and
yeast (Yamanaka et al., 2004). Our recent studies showed that their
functions are redundantly essential for embryogenesis. Simultaneous
depletion of both CDC-48.1 and CDC-48.2 caused a complete
embryonic lethal phenotype (Yamanaka et al., 2004), especially they
play an important role in the progression of meiosis in embryo
(Sasagawa et al., 2007a). In addition to their function in embryogen-
esis, it was revealed that two p97 of C. elegans play essential roles in
ERAD pathway, as the mammalian p97 does (Ye et al., 2001; Mouysset
et al., 2006; Sasagawa et al., 2007b).
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and the functions of p97, little is known about the expression
mechanism of p97 gene. We previously described that the levels and
expression patterns of two p97 proteins are differentially regulated
(Yamauchi et al., 2006). It has been demonstrated that p97 expression
levels correlate with the recurrence and prognosis of several human
cancers (Yamamoto et al., 2003; Tsujimoto et al., 2004). Recently, itwas
revealed that the pre-B-cell leukemia transcription factor 1 (PBX1) is a
key factor for transcription of human p97 (Qiu et al., 2007). Thus, it is
very important to understand the expression regulation of p97 for not
only biological but also medical ﬁelds. In the present study, to clarify
the regulatory mechanisms of differential expression of two p97 pro-
teins of C. elegans, we performed detailed analysis of their 5′ upstream
regions. We identiﬁed two proteins, HMG-12 and CAR-1, involved in
embryonic expression of cdc-48.1, and discuss the promoter structure
of two p97 genes.
Materials and methods
C. elegans culture condition
Wild-type Bristol N2 strain of C. elegans was cultured at 20 °C as described pre-
viously (Brenner, 1974).
Sequence analysis
Sequence alignment was performed using the GENETYX software (Genetyx).
DotPlot comparison was carried out using the CLC DNAWorkbench software (CLC bio).
The nucleotide sequences of 5′ regions of cdc-48.1 and cdc-48.2 of C. elegans and Cae-
norhabditis briggsae were obtained from WormBase (http://www.wormbase.org).
Construction of gfp reporter genes and transgenic worms
Various promoter regions of cdc-48.1 and cdc-48.2 were ampliﬁed from p06-1 and
p41-1 plasmids by PCR with primers (p06 RV and each of p06-1 FW, p06-2 FW, p06-3
FW, p06-4 FW, p06-5 FW, p06-6 FW, and p06-12 FW for cdc-48.1, and p41 RV and each of
p41-1 FW, p41-2 FW, p41-3 FW, p41-4 FW, and p41-5 FW for cdc-48.2) (Table 1). The
resultant fragments were inserted into the pPD95.77 vector to create a translational
fusion to green ﬂuorescent protein (GFP). Site-directed mutagenesis was performed on
p06-1 with mutant primers using the Quick Change Site-Directed Mutagenesis Kit
(Stratagene) to create p06-8, p06-9, p06-10, and p06-11. For internal deletion constructs,
p06-7was prepared fromp06-1 and other constructs (p06-13 to p06-21) were prepared
from p06-7 as follows. Upstream and downstream regions from a deletion region were
ampliﬁedwith primers (p06-1 FWand each #1 primer of p06-13 to p06-21 for upstream
regions, and p06 RV and each #2 primer of p06-13 to p06-21 for downstream regions)
(Table 1), and puriﬁedwithWizard SVGel and PCRClean-up system (Promega). TwoPCR
products were mixed and were annealed in the reaction mixture containing 1× PCR
buffer, 0.2 mM dNTPs at 95 °C for 10min and then 30 °C for 20min. After addition of Ex-
Taq polymerase (TaKaRa), the reactionmixtures were incubated at 72 °C for 10 min, and
then the ordinal PCR reactionwas carried out using p06-1 FWand p06 RV as primers. All
constructs were conﬁrmed by sequencing.
Establishment of transgenic worms was carried out as described previously
(Yamauchi et al., 2006). At least three independent transgenic lines for each GFP
construct were isolated and analyzed. Worms were mounted on 3% agarose pads for
ﬂuorescence microscopy on an Olympus BX51 microscope equipped with a CCD
camera. Adobe Photoshop 6.0 was used for output of images.
Preparation of embryonic nuclear extracts and gel mobility-shift assay
For preparing large quantities of embryos, liquid culture of C. elegans was applied
using Escherichia coli OP50 as a food source, and embryos were obtained by treatment
of gravid hermaphrodites with NaOH and hypochlorite (Stiernagle, 2006). Preparation
of embryonic nuclear extract was performed as described previously (Lichtsteiner and
Tjian, 1995).
Oligonucleotides corresponding to sequences of Element A and Element B were
prepared for gel mobility-shift assay and South-Western blot analysis as a probe. Sense
and anti-sense oligonucleotides (Table 1) weremixed in TEN buffer (10mM Tris–HCl pH
8.0, 1 mM EDTA pH 8.0, 100 mMNaCl), incubated at 95 °C for 10 min, and then gradually
cooled down to the room temperature. Four picomols of the annealed dsDNAs were
labeled using DIG Oligonucleotide 3′-End Labeling Kit (Roche Diagnostics). The
embryonic nuclear extract was pre-incubated with 2 μg of poly[dI–dC] in 40 μl of
binding buffer (10 mM Tris–HCl pH 8.0, 1 mM EDTA, 50 mMNaCl, 5% glycerol and 1 mM
DTT) on ice for 10 min, and incubated with 1 ng of the DIG-labeled probe at 25 °C for
15 min. Reaction mixtures were loaded onto non-denaturing 6% polyacrylamide gel and
subjected to electrophoresis in 0.25× TBE. The resultant DNA–protein complexes were
transferred to a nylonmembrane (HybondN+, GEHealthcare) and detected byusingDIG
Gel Shift Kit (Roche Diagnostics). Unlabeled single-stranded and double-stranded
oligonucleotides were used as competitors.Two-dimensional gel electrophoresis
Two-dimensional (2D) gel electrophoresis of embryonic nuclear extract of C. elegans
was carried out by the method described by Otani et al. (2001) with modiﬁcations.
Brieﬂy, 130 μg of embryonic nuclear extract were prepared in 100 μl of lysis buffer [7 M
urea, 2 M thiourea, 5% N-cyclohexyl-3-aminopropanesulfonic acid (CHAPS), 2% IPG
buffer (GE Healthcare), 50 mM 2-mercaptoethanol] by gentle shaking at room
temperature for 1 h. The supernatant obtained after centrifugation at 13,000×g at 4 °C
for 30 min was treated with 10 μl of DNase/RNase solution (2.5 mg/ml of DNase I and
2.5mg/ml of RNase A) at room temperature for 30min. After addition of equal volume of
rehydration buffer [8 M urea, 0.5% CHAPS, 20 mM DTT, 0.5% IPG buffer and 0.04%
Bromophenol Blue (BPB)] to the sample, ﬁrst-dimension isoelectric focusing gel
electrophoresis was carried out with Immobiline DryStrip pH 3–10 NL (7 cm) (GE
Healthcare) at 200 V for 10 min, 400 V for 10 min, 1000 V for 1 h, and 1500 V overnight.
After electrophoresis, the strip was soaked in equilibration buffer (50 mM Tris–HCl pH
8.7, 6Murea, 30% glycerol,1% SDS,17.7mMDTTand 0.04% BPB) and then in equilibration
buffer containing 0.24 M iodoacetamide instead of DTT at room temperature for 30 min
with gentle shaking.
Second-dimension SDS-PAGEwas performedwith a 17.5% acrylamide gel at 2.5mA/
gel for the ﬁrst 2 h and at 5 mA/gel for additional 6 h. After electrophoresis, gels were
ﬁxed in 10% trichloroacetic acid solution for 1 h and then stained with Coomassie
brilliant blue R250 (CBBR).
South-Western blot analysis
Fractions of embryonic nuclear extract were separated by 2D electrophoresis as
described above and then transferred onto nitrocellulose membranes (PROTRAN,
Whatman). Membranes were stained in dyeing buffer (50% methanol and 0.1% CBBR)
for 1min and then destained in breaching buffer (50%methanol and 10% acetic acid) for
5 min. Subsequent treatments of membrane were performed as described previously
(Ohri et al., 2004). Finally, the binding buffer containing 25 ng/ml of DIG-labeled probes
and 0.25% BSA was added and incubated overnight at room temperature. Membranes
were then washed four times in binding buffer at room temperature for 10 min each.
The chemiluminescent detection of hybridized proteins was performed with a DIG
Luminescent Detection Kit and Nitro-Block II (TM) (Roche Diagnostics).
Identiﬁcation of proteins by MALDI-TOF MS
The CBBR-stained protein spots were excised from the 2D-PAGE gels. The gel pieces
were destained with 200 μl of 30% acetonitrile containing 25 mM ammonium
bicarbonate for 10 min, dehydrated with 50 μl of 100% acetonitrile for 5 min, and
dried for 15 min under vacuum. The proteins were digested in 5 μl of trypsin solution
[10 μg/ml of sequencing grade modiﬁed trypsin (Promega) in 50 mM ammonium
bicarbonate] at 37 °C for over night. The MALDI-TOF samples were prepared by the
sandwich method with a slight modiﬁcation as described previously (Kussmann et al.,
1997). Matrix thin layer was made with 0.5 μl of α-cyano-4-hydroxy-cinnamic acid
(CHCA) solution [1 mg/ml of CHCA (Sigma) in 50% acetonitrile containing 0.1% TFA and
25 mM ammonium bicarbonate] on the sample plate (Applied Biosystems). Aliquots
(1.5 μl) from the trypsin digests were dropped onto the thin layer, dried in air, and
covered with 1 μl of CHCA solution. Mass spectra were acquired by the Voyager DE-STR
(Applied Biosystems) in the mass range of 700–3500 m/z. Two trypsin autolysis peaks
at [M+H]+ 842.5098 and [M+H]+ 2211.1046 were used for internal calibration of each
spectrum. The proteins were identiﬁed by the MS-Fit ProteinProspector (http://
prospector.ucsf.edu/) at ±20 ppm for mass tolerance against NCBInr.
Puriﬁcation of His-tagged recombinant proteins
For construction of His-tagged recombinant proteins, the coding regions of hmg-12
and car-1 genes were ampliﬁed from the cDNA clones (yk1230g1 and yk1535g3,
respectively) by PCR with primers listed in Table 1, and cloned into NheI and BamHI
sites, and NdeI and HindIII sites of the pET28b vector (Novagen), respectively. The
resultant plasmids were used to transform E. coli BL21(DE3) and transformants were
grown at 37 °C in LB medium supplemented with 30 μg/ml kanamycin. The expression
of His-tagged recombinant proteins was induced by the addition of 1 mM IPTG. Cells
from 1-l culture were harvested and suspended in 22.5 ml of buffer A (50 mM Tris–HCl
pH 7.5, 500 mM NaCl, and 20 mM imidazole). After sonication, cleared cell lysates were
obtained by ultracentrifugation (100,000×g) at 4 °C for 1 h and incubated with Ni2+–
NTA agarose (Qiagen) at 4 °C for 1 h. The Ni2+–NTA agarose resin was washed with
buffer A and thenwith buffer B (50mM Tris–HCl pH 7.5, 50 mMNaCl, 20 mM imidazole,
and 10% glycerol). The His-tagged recombinant proteins were ﬁnally eluted with buffer
B containing 200 mM imidazole. Eluted fractions were analyzed by SDS-PAGE and
protein concentration was determined by using BCA Protein Assay Kit (Pierce).
For gel mobility-shift assay, the DIG-labeled probe corresponding to sequences of
element Awas incubatedwith 50, 75, and 100 ng of puriﬁed HMG-12 protein at 25 °C for
15 min. The detection of probe-HMG-12 complex was performed as described above.
RNA interference (RNAi) and Western blot analysis
A part of hmg-12 and car-1 genes was ampliﬁed from cDNA clones (yk1230g1 and
yk1535g3, respectively) by PCR with primers listed in Table 1, and cloned into the
Table 1
Oligonucleotides used in this study
GFP constructs for cdc-48.1
p06 RV TGCGGGATCCGTAACTGAGATTTGGAGCTGG
p06-1 FW GCATGCAACATTTGCCATTGGATGACC
p06-2 FW GCATGCAGACTATTCTCCTCTCGTCTC
p06-3 FW GCATGCCAGCTACATACATTACCGCA
p06-4 FW GCATGCTACAAATACGTCTCGTTATTTAG
p06-5 FW CGATGCTTTGCGTACACTTGTTGAAAAC
p06-6 FW GCATGCTGTGTCGTTTTTAGAAATAATTT
p06-7 1 TCTAAAAACGACACAGTTTGAAAAGGATTTTCACT
2 AAATCCTTTTCAAACTGTGTCGTTTTTAGAAATAA
p06-8 FW TGAAAATCCTTTTCAAACTTAAAGCTAAAATTATAAAGCAACC
RV GGTTGCTTTATAATTTTAGCTTTAAGTTTGAAAAGGATTTTCA
p06-9 FW GAATCACCAAACACTTTTTGAACCCACTTGTTGAAAACACGC
RV GCGTGTTTTCAACAAGTGGGTTCAAAAAGTGTTTGGTGATTC
p06-10 FW TGCGTACACTTGTTGAAAACACAAGTCTATATGCGTGGATGATGACA
RV TGTCATCATCCACGCATATAGACTTGTGTTTTCAACAAGTGTACGCA
p06-11 FW CACGCTTCTATATGCGTGGCCACTGACAATTTTCAAATCTGTGTCG
RV CGACACAGATTTGAAAATTGTCAGTGGCCACGCATATAGAAGCGTG
p06-12 FW GCATGCGGGTGATGCTGCAAATCAT
p06-13 1 ATTTGCAGCATCACCTAAGATTTTGATTCTTGATAGTT
2 AGAATCAAAATCTTAGGTGATGCTGCAAATCATTT
p06-14 1 CGAGACGTATTTGTAAAAATGATTTGCAGCATCACC
2 GCTGCAAATCATTTTTACAAATACGTCTCGTTATTTAG
p06-15 1 ACTGTTATTTGCAATAAAATGATTTGCAGCATCACC
2 GCTGCAAATCATTTTATTGCAAATAACAGTTATTTTTCC
p06-16 1 AATGTATGTAGCTGGAACGCACATCAGCGTTTGGG
2 ACGCTGATGTGCGTTCCAGCTACATACATTACCGC
p06-17 1 GAAACGCAGTTTACAGTCCAGGATGAAAATATGAAAAG
2 ATTTTCATCCTGGACTGTAAACTGCGTTTCCGTTTTCA
p06-18 1 TTCTAAAAACGACACATTTTTTGAAATTTTTCGGAAAAAAG
2 AAAATTTCAAAAAATGTGTCGTTTTTAGAAATAATT
p06-19 1 ATATGCCGTTAGTAAAAAATGATTTGCAGCATCACC
2 GCTGCAAATCATTTTTTACTAACGGCATATCGTTTC
p06-20 1 CATCAGCGTTTGGGATGCAGCACTTTGTAGATCG
2 TACAAAGTGCTGCATCCCAAACGCTGATGTGCGT
p06-21 1 ACTGTTATTTGCAATTCTCGAAACGATATGCCGTTA
2 CATATCGTTTCGAGAATTGCAAATAACAGTTATTTTTCC
GFP constructs for cdc-48.2
p41 RV CCAAGGATCCCAGCTCGTCCATTTTGGCCTG
p41-1 FW CTGCAGCCAGTTTACATGAGGAAAACAA
p41-2 FW CTGCAGAATTACCAGAGTGTGTTATCG
p41-3 FW CTGCAGAACGGTAGAACGCTTTGTGAA
p41-4 FW CTGCAGAGAGAGTGTGAATGAGAGGC
p41-5 FW CTGCAGGCATCTCTTCTTTGATTCGATT
HMG-12 overexpression
FW GCTAGCTCAGACGTTGCTGAAGAGAA
RV GGATCCTTAGTCTGAGCCATCGAAGA
CAR-1 overexpression
FW CATATGTCGAATCAAACACCGTAC
RV AAGCTTATTGTTCGGCAGCTGCG
hmg-12 RNAi
FW CTCGAGTCAGACGTTGCTGAAGAGA
RV TCTAGACTTCAGCGGCAGTTTTCTTC
car-1 RNAi
FW AAGCTTACTTCCAAGCTAACCGTGG
RV TCTAGACTCCATATCCGCGGTTTCC
Gel mobility-shift assay
element A
Sense AGACTATTCTCCTCTCGTCTCGTTTCACATCTCTTCGTTCTCCGTCTATCGATCG
Anti-sense CGATCGATAGACGGAGAACGAAGAGATGTGAAACGAGACGAGAGGAGAATAGTCT
Element B
Sense TATCGATCTACAAAGTGCTGCAT
Anti-sense ATGCAGCACTTTGTAGATCGATA
350 S. Yamauchi et al. / Developmental Biology 318 (2008) 348–359LITMUS 28 vector (New England Biolabs). Using the resultant plasmids as template, we
ampliﬁed DNA fragments by PCR with the T7 primer. The PCR products were used as
templates for in vitro transcription by T7 RNA polymerase (TaKaRa). To knock-down
hmg-12 and car-1 expression, we took the soaking RNAi method (Maeda et al., 2001).
Brieﬂy, 100 to 200 L1 larvae were soaked in 12 μl of 1.25×M9 buffer containing 15 mMspermidine, 0.25% gelatin and ∼8 μg of dsRNA, for 24–48 h. RNAi-treated L1 larvae were
then grown into adult on seeded plates.
Lysates of embryos from hmg-12(RNAi) or car-1(RNAi) worms were prepared.
Concentration of lysates was determined by DC Protein Assay kit (Bio-Rad). Western
blot analysis was carried out as described previously (Yamauchi et al., 2006).
351S. Yamauchi et al. / Developmental Biology 318 (2008) 348–359Results
Promoter structure of two p97 genes of C. elegans
C. elegans possesses two genes for p97, named cdc-48.1 and cdc-
48.2, whose expression patterns and protein levels were differentially
regulated (Yamanaka et al., 2004; Yamauchi et al., 2006). To investigate
molecularmechanisms of their expression regulation, we ﬁrst injected
the initial construct, p06-1, containing 765 bp upstream of the
translational start site of cdc-48.1 in translational fusion to the reporter
GFP (Fig. 1A), and analyzed transgenic worms. As shown in Fig. 1B,
CDC-48.1∷GFP derived from p06-1 was ubiquitously expressed,
predominantly in spermathecae at adult stage and in embryos. We
then prepared serial deletions of the cdc-48.1 promoter and analyzed
expression pattern of GFP (Fig.1). Pattern of GFP signal fromp06-2was
essentially the same as that from p06-1, indicating that the region
upstream of −669 bp is not necessary for a normal cdc-48.1 expression.
When deleted up to the position −444 bp (p06-3), GFP expression in
embryos, but not in larvae and adult, was abolished. This result
suggests that a cis-regulatory element for the expression in embryos is
located between −669 bp and −444 bp in the cdc-48.1 promoter region.
When further deleted up to the position −181 bp (p06-5), GFP
expression in larvae and adult was also abolished, suggesting that
another cis-regulatory element is located between −300 bp and
−181 bp. It should be noted that the GFP expression in posterior gut
cells from p06-5 (Fig. 1B) and p06-6 (data not shown) is due to unc-54
3′-UTR sequence contained in pPD95.77 vector (Boulin et al., 2006).
When deleted up to the position −54 bp, GFP expression in posterior
gut cells was nomore observed (data not shown). In addition, we have
previously shown that cdc-48.1 transcripts were trans-spliced to SL1 at
−19 bpposition (Yamauchi et al., 2006). Thus, these results suggest that
the region from −121 bp to −54 bp of cdc-48.1 contains a minimal
promoter sequence. It is interesting to mention that this region isFig.1.Deletion analysis of the cdc-48.1 promoter region. (A) GFP reporter constructs inwhich
schematically. (B) Each construct was microinjected into C. elegans and transgenic worm lin
Nomarski optics view and left panel shows the ﬂuorescence view. The spermathecae expres
also summarized in panel A. When GFP expression was positive or negative, represented byhighly A+T rich (75%), and that one TATA sequence is found at −67 bp
to −64 bp.
We next analyzed the expression pattern of cdc-48.2 in the same
way as for cdc-48.1. In the initial construct, p41-1, containing 1277 bp
upstream of the translational start site of cdc-48.2, CDC-48.2∷GFP was
expressed mainly in embryos (Fig. 2). Although the deletion of
−1277 bp to −375 bp region did not affect GFP expression, deletion
of −375 bp to −326 bp region led to clearly abolish GFP expression in
embryos (p41-4 in Fig. 2). These results suggest that a cis-regulatory
element for the expression in embryos is located between −375 bp and
−326 bp in the cdc-48.2 promoter. Again, when deleted up to the
position −75 bp, GFP expression in posterior gut cells was no more
observed (data not shown). We have previously shown that cdc-48.2
transcripts were trans-spliced to SL1 at −17 bp position (Yamauchi et
al., 2006). These results thus suggest that a minimal promoter of cdc-
48.2 exists between −200 bp and −75 bp, in which one TATA sequence
is found at −155 bp to −152 bp. Taken together, promoter structure of
two p97 genes of C. elegans seems to be quite different.
Three conserved sequences are essential for cdc-48.1 expression at
post-embryonic stages
One strategy to identify the elements regulating expression of C.
elegans genes is to compare the promoter sequence of C. elegans with
the homologous sequence in the related-nematode C. briggsae. It is
known that intergenic and intronic sequences between these
nematodes have diverged considerably, whereas both sequences and
functions of the regulatory elements are common to these two species
(Gilleard et al., 1997). In order to identify regulatory elements, we
performed a dot matrix comparison (CLC DNA Workbench 3) on the
promoter sequences of two p97 genes in both nematode species. We
clearly found a conserved block of sequences from −256 bp to −122 bp
in the cdc-48.1 promoter (Fig. 3A), while no conserved block of se-decreasing regions of the cdc-48.1 promoter were translationally fused to GFP are shown
es were observed under the microscope. Photos are in pairs; the right panel shows the
sing GFP are indicated by white arrowheads. Scale bar, 100 μm. Expression patterns are
+ or −, respectively.
Fig. 2. Deletion analysis of the cdc-48.2 promoter region. (A) GFP reporter constructs in which decreasing regions of the cdc-48.2 promoter were translationally fused to GFP are
shown schematically. (B) Each construct was microinjected into C. elegans and transgenic worm lines were observed under the microscope. Photos are in pairs; the right panel shows
the Nomarski optics view and left panel shows the ﬂuorescence view. GFP expressing embryos in uterus are indicated by white arrows. Scale bar, 100 μm. Expression patterns are also
summarized in panel A. When GFP expression was positive or negative, represented by + or −, respectively.
Fig. 3. cdc-48.1 promoter contains conserved blocks of sequences. (A) Dotmatrix comparison of 765 bp of the 5′ upstream regions of cdc-48.1 in C. elegans and C. briggsae. A conserved
region is indicated by an arrow. (B) Dot matrix comparison of 1277 bp of the 5′ upstream regions of cdc-48.2 in C. elegans and C. briggsae. (C) Sequence alignment of the conserved
region of cdc-48.1 in C. elegans (Ce) and C. briggsae (Cb). Asterisks indicate nucleotide identity in C. elegans and C. briggsae. Four well-conserved boxes (a–d) are in bold face and boxed.
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353S. Yamauchi et al. / Developmental Biology 318 (2008) 348–359quences was found in the cdc-48.2 promoter (Fig. 3B). Sequence align-
ment of the conserved block is shown in Fig. 3C. In this region, four
distinct, well-conserved sequences (Box a to d) were identiﬁed. Then,
we analyzed whether this conserved block plays an active role in cdc-
48.1 expression at post-embryonic stages. When the entire region of
this conserved block was deleted (p06-7), GFP expression at larval and
adult stages, but not in embryos, was abolished (Fig. 4). When deleted
up to −181 bp (p06-5), no specialized GFP expressionwas observed as
shown in Fig. 1. Furthermore, introduction of point mutations at Box a
(p06-8) caused a loss of GFP expression at larval and adult stages,
indicating that Box a in the conserved block plays an important role in
expression at post-embryonic stages. Besides Box a, there can be
identiﬁed three additional, highly conserved boxes (Box b, Box c and
Box d) (Fig. 3C). When Box b or Box c was mutated (p06-9 or p06-10),
GFP was no longer expressed at larval and adult stages as same as
observed with p06-8 (Fig. 4). These results indicate that conserved
boxes, Box a, Box b, and Box c, are essential for cdc-48.1 expression at
post-embryonic stages. In contrast, the p06-11 construct in which the
conserved box, Box d, was mutated showed the GFP expression
normally, implying that Box d is unnecessary for cdc-48.1 expression at
post-embryonic stages (Fig. 4).
Two regulatory elements are necessary for cdc-48.1 expression in
embryos
We demonstrated that regulatory elements for cdc-48.1 expression
in embryos are located between −669 bp and −444 bp of the cdc-48.1
promoter (p06-2 and -3 in Fig. 1A). However, no conserved block of
sequences was found in this region between C. elegans and C. briggsaeFig. 4. Mutational analysis of the regions necessary for post-embryonic expression in the cd
translationally fused to GFP are shown schematically. Four boxes represent well-conserved
site. + and − indicate that GEP expressionwas and was not seen. (B) Each construct was micro
microscope. GFP-expressing spermathecae and embryos are indicated by white arrowheadsby means of a dot matrix comparison (Fig. 3A). To identify functional
elements, we analyzed reporter constructs sequentially deleted from
−669 bp to −444 bp more precisely. When the −669 bp to −614 bp
region was deleted, GFP expression in embryos was completely
abolished (p06-12 and p06-13 in Fig. 5A). Interestingly, GFP expression
in embryos was also lost in worms injected with p06-14 that contains
the −765 bp to −593 bp region, indicating the 55-bp region (−669 bp to
−614 bp) is necessary but not sufﬁcient for cdc-48.1 expression in
embryos. To search for an additional element, we next analyzed
reporter constructs sequentially deleted downstream region from
−614 bp.We found that deletion of the region from −593 bp to −525 bp
caused a loss of GFP expression in embryos (p06-15 in Fig. 5). Analysis
of smaller internal deletions in the −593 bp to −525 bp region showed
that the 23-bp region (from −593 bp to −570 bp) is additionally
required for cdc-48.1 expression in embryos (p06-19, p06-20 and p06-
21 in Fig. 5A). Other deletions (p06-16, p06-17 and p06-18) did not
affect the GFP expression in embryos. Taken together, two regulatory
regions were identiﬁed to control embryonic expression of cdc-48.1,
namely one is the 55-bp region (−669 bp to −614 bp) and the other is
the 23-bp region (−593 bp to −570 bp).We hereafter refer to the 55-bp
region and the 23-bp region as Element A and Element B, respectively
(Fig. 5B).
Identiﬁcation of proteins that bind to Element A and Element B
In an initial attempt to identify transcription factors that contribute
to cdc-48.1 expression in embryos, we examined whether C. elegans
embryonic nuclear extracts contain proteins that bind to Element A
and Element B. Gel mobility-shift assays were conducted using DIG-c-48.1 promoter. (A) GFP reporter constructs in which mutated cdc-48.1 promoter was
boxes of the cdc-48.1 promoter between C. elegans and C. briggsae. X indicates mutated
injected into C. elegans and transgenic worm lines were observed under the ﬂuorescent
and arrows, respectively. Scale bar, 100 μm.
Fig. 5. Identiﬁcation of two elements involved in embryonic expression of cdc-48.1. (A) GFP reporter constructs in which decreasing regions of the cdc-48.1 promoter were
translationally fused to GFP are shown schematically. Each construct was microinjected into C. elegans and transgenic worm lines were observed under the ﬂuorescent microscope.
+ and − indicate that GEP expression was and was not seen. Two elements essential for the cdc-48.1 expression in embryo are shown as a white box (Element A) and a black box
(Element B) and their sequences are also shown (B).
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Element B sequence as probes. Single shifted band was detected with
each regulatory element (lanes 2–3 in Figs. 6A, B). To verify their
binding speciﬁcities to each element, we performed the competition
assays. Unlabeled oligonucleotides with the identical sequences were
used as speciﬁc competitors. Both regulatory elements, binding
activities were signiﬁcantly reduced by co-incubationwith the speciﬁc
competitors (lanes 4–6 in Figs. 6A, B). Co-incubation with unlabeled
oligonucleotides with non-related sequences did not affect band shift
(lanes 7–9 in Figs. 6A, B). These results suggest the existence of two
distinct proteins that speciﬁcally bind to Element A and Element B of
the cdc-48.1 promoter.
To identify the proteins that bind to Element A and Element B from
C. elegans embryonic nuclear extracts, we resolved embryonic nuclear
extracts by 2D gel electrophoresis, and performed South-Western blot
analyses with DIG-labeled probes. Both probes hybridized to the spots
resolved in the basic region: the hybridized spot with Element A,
apparent molecular size and pI were 46 kDa and 9.5; the hybridizedspots with Element B, apparent molecular size and pI were 42 kDa and
9.0, 42 kDa and8.5, and42 kDa and8.3, respectively (Fig. 7). Hybridized
spots were excised from the gels and trypsinized, and the resulting
peptides were analyzed by mass spectrometry using a MALDI-TOF on
the basis of peptidemass matching. As a result, we found that proteins
bound to Element A and Element BwereHMG-12 (Y17G7A.1) and CAR-
1 (Y18D10A.17), respectively. Note that three spots with same mole-
cular size butwith different pI detectedwith the Element B probewere
all identiﬁed as CAR-1 (Fig. 7B), suggesting that CAR-1 has somemodi-
ﬁcation, although we have not deﬁned the type of modiﬁcation. In
WormBase (http://www.wormbase.org), HMG-12 is deﬁned as a high
mobility group protein, contains DNA binding domain called AT-hook
motif, and has calculatedmolecular size 33 kDa and pI 9.64, while CAR-
1 is deﬁned as a cytokinesis, apoptosis, RNA-associated protein, and
has calculated molecular size 38 kDa and pI 9.46. It should be men-
tioned that, although apparent pIs of both proteins are consistent with
calculated ones, their apparent molecular sizes seem to be larger than
calculated ones (see below).
Fig. 6. Detection of factors that speciﬁcally bind to Element A and Element B. Gel mobility-shift assays were performed using embryonic nuclear extract and DIG-labeled probes
containing Element A (A) and Element B (B) sequences. Lane 1: probe only (1 ng), 6.6 μg (lanes 2) and 11 μg (lanes 3–9) of embryonic nuclear extractwere added. Competitors were co-
incubated in lanes 4–15. Co-incubated competitors are: lanes 4–6, unlabeled dsDNAwith sequences of Element A (A) and Element B (B) as a sequence-speciﬁc competitor, lanes 7–9,
unlabeled dsDNAwith sequences of Element B (A) and Element A (B) as a nonspeciﬁc competitor, lanes 10–12 unlabeled sense-oligonucleotidewith sequences of Element B (B), lanes
13–15 unlabeled anti-sense-oligonucleotide with sequences of Element B (B). Twenty-ﬁve-times (lanes 4, 7, 10 and 13), ﬁfty-times (lanes 5, 8, 11 and 14) and hundred-times (lanes 6,
9, 12 and 15) of competitors were used.
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We then investigated whether both HMG-12 and CAR-1 regulate
cdc-48.1 expression in embryos. First, to examine whether theseFig. 7. Identiﬁcation of proteins that bind to Element A and Element B. South-Western blo
containing Element A (A) and Element B (B) sequences. Left panels show the results of 2D g
results of South-Western blot analyses. Proteins corresponding to the spots (arrows) identiﬁproteins are indeed able to bind to each element in vitro, we performed
gel mobility-shift assays using DIG-labeled probes and bacterially
expressed recombinant proteins. Bacterially expressed recombinant
HMG-12 andCAR-1migratedon the SDS-PAGEgel at 48 kDa and45kDa,t analyses were carried out using embryonic nuclear extract and DIG-labeled probes
el electrophoresis of embryonic nuclear extract of C. elegans, and right panels show the
ed by South-Western blot analyses are shown at middle panels.
Fig. 8. Both HMG-12 and CAR-1 are involved in embryonic expression of cdc-48.1. (A) HMG-12 speciﬁcally binds to Element A. A gel mobility-shift assay was performed using the
recombinant HMG-12 protein and the DIG-labeled probe containing Element A sequence. Lane 1: probe only (1 ng), 50 ng (lanes 2), 75 ng (lane 3) and 100 ng (lanes 4–10) of puriﬁed
HMG-12 were added. Competitors were co-incubated in lanes 5–10. Co-incubated competitors are unlabeled dsDNAwith sequences of Element A as a sequence-speciﬁc competitor
(lanes 5–7), and unlabeled dsDNAwith sequences of Element B as a nonspeciﬁc competitor (lanes 8–10). Twenty-ﬁve-times (lanes 5 and 8), ﬁfty-times (lanes 6 and 9) and hundred-
times (lanes 7 and 10) of competitors were used. (B and C) Effects of RNAi of hmg-12 and car-1 on embryonic expression of cdc-48.1were analyzed. Transgenic worms microinjected
with p06-7 (Fig. 4A) were used. The soaking RNAi method was applied. L1 larvae were soaked in M9 buffer containing dsRNA for 24–48 h. RNAi-treated L1 larvae were then grown
into adult on seeded plates and observed under the microscope. (B) Photos are in pairs; the left panel and the right panel show the Nomarski optics view and the ﬂuorescence view,
respectively. Upper panel shows a control worm immersed in water, middle panel a worm of hmg-12(RNAi), and lower panel a worm of car-1(RNAi). Scale bar, 100 μm. (C) Embryos
were prepared from RNAi-treated worms and the amount of p97 in embryos were analyzed byWestern blotting. The same amount of total proteins was resolved in each lane (1.5 μg
for Western blotting and 4.5 μg for CBBR staining). Four protein bands with asterisks on the CBBR stained gel were quantiﬁed and used as a loading control. Relative amounts of p97
between control and RNAi samples are also shown.
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molecular size on the 2Dgels (Fig. 7), supporting that identiﬁed spots by
South-Western blot are HMG-12 and CAR-1. We found speciﬁc binding
of puriﬁed HMG-12 to Element A but not to Element B in vitro (Fig. 8A),
and the band shift showed the same pattern as the embryonic nuclear
extractswere used (Figs. 6A and 8A). Unfortunately, wewere not able to
test the CAR-1 binding to Element B in gel mobility-shift assay because
CAR-1 has not been recovered in a soluble form so far.
Second, to analyze the function of HMG-12 and CAR-1 on the
expression of cdc-48.1 in vivo, we knocked down hmg-12 and car-1
expression on theworms harboring p06-7,which contains the cdc-48.1
promoter region only involved in embryonic expression (Fig. 4A), by
means of soaking RNAi method. When the worms were treated with
hmg-12 RNAi, GFP expression in embryos was only slightly decreased
(Fig. 8B). However, the level of p97 proteins in embryos prepared from
hmg-12(RNAi)worms was signiﬁcantly reduced (Fig. 8C). In the case of
car-1(RNAi), RNAi effects were more prominent. GFP expression in
embryos was completely abolished (Fig. 8B), and the amount of p97
proteins was also signiﬁcantly reduced in embryos prepared from car-
1(RNAi) worms (Fig. 8C). Taken together, these results indicate that
bothHMG-12 and CAR-1 play important roles in embryonic expression
of cdc-48.1.Discussion
C. elegans uniquely possesses two p97 homologues, and their
expression patterns and levels were differently regulated: CDC-48.1 is
ubiquitously expressed through all developmental stages, while CDC-
48.2 is mainly expressed at embryonic stage. The amount of CDC-48.1
is almost double to that of CDC-48.2 (Yamanaka et al., 2004; Yamauchi
et al., 2006). In this study, we analyzed promoter regions of C. elegans
cdc-48.1 and cdc-48.2 genes to understand molecular mechanisms of
differential expression of two p97 homologues. Mutation analysis of
their promoter regions revealed that the promoter of cdc-48.1 contains
two regions necessary for embryonic and post-embryonic expression,
while the promoter of cdc-48.2 contains the single region necessary for
embryonic expression (Figs. 1–5). Sequence comparison between the
region necessary for embryonic expression of cdc-48.1 and cdc-48.2
did not show any signiﬁcant homology (data not shown). These results
suggest that differential expression patterns of two p97 proteins in C.
elegans are dependent on each promoter. Mutations in the region
necessary for embryonic expression of cdc-48.1 caused a loss of
embryonic expression but not of post-embryonic expression (Figs. 1
and 5). Conversely, mutations in the region necessary for post-em-
bryonic expression caused a loss of post-embryonic expression but not
Fig. 9. Promoter structures of two p97 genes of C. elegans. The cdc-48.1 promoter contains two modules: one is essential for embryonic expression [Element A (white box) and
Element B (black box)] and the other for post-embryonic expression [Box a, Box b and Box c (gray boxes)]. HMG-12 and CAR-1 would bind to Element A and Element B, respectively,
and play a crucial role for embryonic expression of cdc-48.1. The cdc-48.2 promoter contains the region only involved in embryonic expression (hatched box).
357S. Yamauchi et al. / Developmental Biology 318 (2008) 348–359of embryonic expression (Figs. 1 and 4). These results suggest that two
cis-regulatory elements in the cdc-48.1 promoter region function
independently of each other.
Comparison of the promoter sequences between C. elegans and C.
briggsae has been shown to be a powerful tool to identify elements
regulating gene expression (Hwang and Lee, 2003; Hong et al., 2004;
Zhao et al., 2005; Wagmaister et al., 2006). Dot matrix comparison of
the promoter sequences of C. elegans and C. briggsae revealed a con-
served block of sequences in the cdc-48.1 promoter, which corresponds
to the region necessary for post-embryonic expression in the present
study (Fig. 3). This suggests that the regulatory mechanism for post-
embryonic expression of cdc-48.1 would be well conserved in C.
elegans and C. briggsae. A series of mutation analysis of this conserved
block further deﬁned that three well-conserved boxes, Box a, Box b,
and Box c, play an important role in post-embryonic expression (Figs. 3
and 4). We have previously demonstrated that CDC-48.1∷GFP was
expressed ubiquitously, including several head neurons, ventral cord,
vulval muscles, and spermathecae, at larval and adult stages (p06-1 in
Fig. 1B; Yamanaka et al., 2004; Yamauchi et al., 2006). When even one
of the three well-conserved boxes was mutated, GFP expression was
abolished in all tissues, except for embryos in uterus (p06-8, p06-9 and
p06-10 in Fig. 4B). These results implicated that these boxes control
cdc-48.1 expression in a developmental stage speciﬁc, but not tissue
speciﬁc manner. No band shift was observed in gel mobility-shift
assays using embryonic nuclear extracts and probes with identical
sequences with these well-conserved boxes (data not shown),
suggesting that regulatory factors involved in post-embryonic expres-
sion of cdc-48.1 are mainly expressed at larval and adult stages. On the
other hand, no conserved block of sequences was detected in the
regions for embryonic expression of cdc-48.1 and cdc-48.2 genes by
means of dot matrix comparison between C. elegans and C. briggsae
(Fig. 3).
Detailed deletion analysis of the region necessary for embryonic
expression in the cdc-48.1 promoter revealed that two cis-regulatory
elements, Element A and Element B are essential for cdc-48.1
expression in embryos (Fig. 5). By using South-Western blotting and
MALDI-TOF MS analysis, we identiﬁed HMG-12 and CAR-1 as proteins
that bind to Element A and Element B, respectively (Fig. 7). HMG-12 of
C. elegans is deﬁned as a high mobility group (HMG) protein and be-
longs to HMGI/Y families (referred as HMGA) (Reeves and Beck-
erbauer, 2001; Okkema and Krause, 2005). In mammals, HMGA pro-
teins bind to the minor groove of stretches of AT-rich DNA via the AT
hook motif, and facilitate recruitment of other transcription factors to
the enhancer (Reeves and Beckerbauer, 2001). C. elegans HMG-12 is
also predicted to contain seven AT hook motifs in WormBase (http://
www.wormbase.org). hmg-12(RNAi) worms show embryonic lethal
phenotype (http://www.wormbase.org), suggesting that HMG-12might be expressed in embryo similarly to CDC-48.1. Puriﬁed HMG-
12 bound to double-stranded Element A, but not to non-related
sequence, such as Element B (Fig. 8). Thus, HMG-12 protein spe-
ciﬁcally binds to Element A and may recruit other transcription factor
(s) or may induce structural changes in chromatin to activate the cdc-
48.1 expression in embryos. A slight but signiﬁcant reduction of the
levels of exogenous CDC-48.1∷GFP expression and endogenous p97
proteins was indeed observed in embryos prepared from hmg-12
(RNAi) worms (Figs. 8B, C), implying an important role of HMG-12 in
the cdc-48.1 expression in embryos. It should be noted that the ge-
nome of C. elegans has nine genes that encode putative HMG proteins
including two HMGA family proteins, HMG-11 and HMG-12 (Okkema
and Krause, 2005). Therefore, it is likely that other HMG proteins of C.
elegans may compensate the cdc-48.1 expression in hmg-12(RNAi)
embryos to some extent.
Another protein CAR-1 was identiﬁed as a protein that binds to
Element B (Fig. 7B). CAR-1 has been named for cytokinesis, apoptosis
and RNA (Audhya et al., 2005). CAR-1 contains several clustered RGG
motifs suggestive of an RGG box, which is found in numerous RNA-
binding proteins (Burd and Dreyfuss, 1994), and belongs to a family of
novel Sm-like proteins, which associate with RNA-binding proteins
(Albrecht and Lengauer, 2004; Audhya et al., 2005). Therefore, CAR-1
has been implicated in RNA metabolism. In this study, by means of gel
mobility-shift assays, binding activities of the protein in embryonic
nuclear extracts to Element B were not changed in co-incubationwith
sense and anti-sense, single-stranded oligonucleotides of sequences of
Element B as a competitor (Fig. 6B). This suggests that the protein
binding to Element B speciﬁcally recognizes double-strandedDNA, but
not single-stranded DNA. Although we were not able to conﬁrm the
binding of CAR-1 to Element B directly in vitro because of CAR-1's
insolubility during puriﬁcationprocesses, RNAi analyses demonstrated
that CAR-1 undoubtedly plays a crucial role in the cdc-48.1 expression
in embryos (Figs. 8B, C). It has been reported that depletion of CAR-1
signiﬁcantly disrupts the spindle formation and ER organization in
embryos. Therefore, CAR-1 was suggested to be required for cytokin-
esis and membrane trafﬁcking in C. elegans embryos (Audhya et al.,
2005; Squirrell et al., 2006). It is very interesting to mention that p97
has been demonstrated to play an important role in ER maintenance
during interphase as well as in ER assembly at the end of mitosis
(Uchiyama and Kondo, 2005; Uchiyama et al., 2006). Furthermore, it
has been reported that RNAi of p97 causes spindle defects and induces
apoptosis (Kobayashi et al., 2002; Wójcik et al., 2004). Taken together,
it is thus reasonable to assume that the observed defects by depletion
of CAR-1 resulted from the reduction of the cdc-48.1 expression. Then,
how is cdc-48.1 expression regulated developmentally? CAR-1 is
mainly expressed in germline and in early embryonic stage. However,
CAR-1 level was gradually reduced after 4-cell stage (Boag et al., 2005).
358 S. Yamauchi et al. / Developmental Biology 318 (2008) 348–359Therefore, we consider that the reduction of CAR-1 level in late
embryonic stage is at least one factor to regulate cdc-48.1 expression
developmentally. Further studies should be directed towards how
CAR-1 regulates the cdc-48.1 expression in embryos.
In summary, we were able to reveal the promoter structure of two
p97 genes of C. elegans, and showed that HMG-12 and CAR-1 are
involved in the cdc-48.1 expression in embryos (Fig. 9). We are now
trying to identify proteins that are required for post-embryonic ex-
pression of cdc-48.1 and for embryonic expression of cdc-48.2. Since
p97 is a multi-functional protein as described above, clarifying the
whole picture of the expression regulation of two p97 genes in C.
elegans will give us some clues to understand not only their common
functions but also speciﬁed functions of each p97.
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